Bavarian Nordic A/S Reports Positive Data from First EUA Enabling Study with Imvamune Smallpox Vaccine

KVISTGAARD, Denmark, Nov. 29, 2007-Bavarian Nordic reports the successful completion of a large, placebo-controlled Phase II trial in 745 healthy subjects who received either one or two doses of Imvamune third-generation smallpox vaccine. The...